Gene · 8915
Papers2,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Information transfer in mammalian glycan-based communication. | Elife | 2023 | 36803584 | PubTator, text mining | PubMed |
| Finding a vocation for validation: taking proteomics beyond association and location. | RSC Chem Biol | 2023 | 36794020 | PubTator, text mining | PubMed |
| Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the Challenge. | Mod Pathol | 2023 | 36788062 | PubTator, text mining | PubMed |
| A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe? | Transl Oncol | 2023 | 36773442 | PubTator, text mining | PubMed |
| Incorporating knowledge of disease-defining hub genes and regulatory network into a machine learning-based model for predicting treatment response in lupus nephritis after the first renal flare. | J Transl Med | 2023 | 36737814 | PubTator, text mining | PubMed |
| Autosomal Recessive Inflammatory Skin Disease Caused by a Novel Biallelic Loss-of-Function Variant in CARD11. | J Clin Immunol | 2023 | 36729250 | PubTator, text mining | PubMed |
| The landscape overview of CD47-based immunotherapy for hematological malignancies. | Biomark Res | 2023 | 36726125 | PubTator, text mining | PubMed |
| Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma. | J Clin Invest | 2023 | 36719376 | PubTator, text mining | PubMed |
| The paracaspase MALT1 is a downstream target of Smad3 and potentiates the crosstalk between TGF-β and NF-kB signaling pathways in cancer cells. | Cell Signal | 2023 | 36708753 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| CARD14 Missense Variant Underlying CARD14-Associated Papulosquamous Eruption with Beneficial Response to Secukinumab. | JID Innov | 2023 | 36699196 | PubTator, text mining | PubMed |
| Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial. | Blood Adv | 2023 | 36696540 | PubTator, text mining | PubMed |
| A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review. | Int J Mol Sci | 2023 | 36674968 | PubTator, text mining | PubMed |
| The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications. | Int J Mol Sci | 2023 | 36674939 | PubTator, text mining | PubMed |
| The role of autophagy in viral infections. | J Biomed Sci | 2023 | 36653801 | PubTator, text mining | PubMed |
| CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. | Nat Commun | 2023 | 36639382 | PubTator, text mining | PubMed |
| Comprehensive multi-omic profiling of somatic mutations in malformations of cortical development. | Nat Genet | 2023 | 36635388 | PubTator, text mining | PubMed |
| Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. | Int J Mol Sci | 2023 | 36614292 | PubTator, text mining | PubMed |
| Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation. | Nat Commun | 2023 | 36609400 | PubTator, text mining | PubMed |
| Immune responses to human fungal pathogens and therapeutic prospects. | Nat Rev Immunol | 2023 | 36600071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8915/papers?page=15